drugset / Trial / NCT03670836

Comparison of Misoprostol Ripening Efficacy With Dilapan

NCT03670836 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if Dilapan works as well as Misoprostol for preparing the mouth of the uterus (cervix) for inducing labor in women who need to undergo this procedure. The primary objective is to assess the efficacy of Dilapan for cervical ripening compared to Misoprostol in women undergoing Induction of labor (IOL) at or more than 37 weeks gestation.

Timeline

Start
2018-11-15
Primary completion
2021-07-21
Completion
2021-07-21

Outcome

Met primary endpoint

paper The proportion of women achieving vaginal delivery within 36 hours was higher with mechanical cervical dilation compared with misoprostol (61.6% vs 59.2%), with an absolute difference of 2.4% (95% CI -9% to 13%), indicating noninferiority for the prespecified margin. PMID 35675605 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 25 ug Oral

Indications

No indication recorded.